Home 2019-02-20T12:13:45+00:00


At M4K Pharma, we are using open science to revolutionize how affordable new treatments are discovered and developed. Through our Medicines4Kids program, we will aggregate and align the work of global academics, foundations and industry researchers to advance new cures for childhood diseases not well-served by current business models.

M4K Pharma’s Data:
In line with M4K Pharma’s open science principles, we are committed to sharing our research data freely in the public domain. Our data is currently available for public viewing in the video recordings of our monthly open scientific updates, which are posted to our Blog and also available through our YouTube Channel. Data will be openly available in a downloadable format soon.

How the pain of loss can help create hope for others. @AbbiesArmy charity funds #openscience research at @ICR_London for DIPG. @M4KPharma is taking the breakthroughs forward with a promise of affordable treatments https://t.co/8w04TyJ0Cp

Ellie Williams @thesgconline purifies variants of the proteins ALK2 and SUFU. #Openscience report: https://t.co/Zusms8BLl1 Blog: https://t.co/knX9CDQHVC @M4Kpharma @DefeatDIPG @FOPFriends

This is a wonderful development. We underestimate the role that the public sector can play — all the way through to development and distribution — in drug development. We rely too much on the private sector. We need more of this & other publicly oriented actors such as @M4KPharma https://t.co/O4TULREjT3

If you missed this virtual meeting, here's the recording: https://t.co/FAk7a6sFg3

What does Open-AD mean by #openscience? Like @thesgconline & @M4KPharma, Open-AD is “all-in” open. We’ll freely share data and materials prior to publication, and never patent anything as a core principle. Kudos to @nih for supporting this. “Knowledge belongs to no country" https://t.co/lC6saKJ06P

Load More...

Latest Blog Posts